ISIN | CH0269987423 |
---|---|
Valor Number | 26998742 |
Bloomberg Global ID | |
Fund Name | Bellevue Biotech CA CHF |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland | |
Distributor(s) |
Zürcher Kantonalbank Zürich Phone: +41 44 293 93 93 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | Special conditions apply to the issue of units |
Redemption Condition | Special conditions apply to the redemption of units |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 102.08 CHF | 02.04.2025 |
---|---|---|
Previous Price * | 100.64 CHF | 01.04.2025 |
52 Week High * | 112.44 CHF | 16.07.2024 |
52 Week Low * | 95.86 CHF | 19.04.2024 |
NAV * | 102.08 CHF | 02.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 27,470,296 | |
Unit/Share Assets *** | 5,769,297 | |
Trading Information SIX |
YTD Performance | -1.44% |
31.12.2024 - 02.04.2025
31.12.2024 02.04.2025 |
---|---|---|
1 month | -4.80% |
03.03.2025 - 02.04.2025
03.03.2025 02.04.2025 |
3 months | -3.29% |
03.01.2025 - 02.04.2025
03.01.2025 02.04.2025 |
6 months | -1.39% |
02.10.2024 - 02.04.2025
02.10.2024 02.04.2025 |
1 year | +0.07% |
02.04.2024 - 02.04.2025
02.04.2024 02.04.2025 |
2 years | +0.35% |
03.04.2023 - 02.04.2025
03.04.2023 02.04.2025 |
3 years | -7.84% |
04.04.2022 - 02.04.2025
04.04.2022 02.04.2025 |
5 years | +19.39% |
02.04.2020 - 02.04.2025
02.04.2020 02.04.2025 |
Equity Participation Rate in % | 80.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Gilead Sciences Inc | 9.91% | |
---|---|---|
Amgen Inc | 8.58% | |
Vertex Pharmaceuticals Inc | 7.55% | |
Regeneron Pharmaceuticals Inc | 6.19% | |
AstraZeneca PLC ADR | 4.26% | |
Alnylam Pharmaceuticals Inc | 3.62% | |
argenx SE ADR | 3.18% | |
Verona Pharma PLC ADR | 3.16% | |
BeiGene Ltd ADR | 2.73% | |
Illumina Inc | 2.04% | |
Last data update | 28.02.2025 |
TER | 1.52% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | 10.00% |
PTR | |
Max. Management Fee *** | 1.80% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |